Together, these findings provide initial evidence suggesting that inhibition of HDAC activity, in particular selective targeting of HDAC3, may be clinically beneficial in suppressing inflammation and promoting tissue regeneration in periodontitis (Table 1). Here, HDAC9 is linked to periodontitis.